AvKare Recalls Trazodone Hydrochloride Tablets Due to Sildenafil Packaging Mix-Up
AvKare Inc. is recalling 14,368 bottles of Trazodone Hydrochloride Tablets 100 mg because they were inadvertently packaged with sildenafil.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The recall is classified as FDA Class I, which meets the rubric criteria for a Critical severity score due to the potential for serious adverse health consequences.
Plain-English summary
AvKare Inc. is recalling 14,368 bottles of Trazodone Hydrochloride Tablets USP 100 mg (NDC 42291-834-10). The affected product is Lot 36783 with an expiration date of 06/2022. The recall is due to a product mix-up where bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a third-party facility.
The recalled product was distributed nationwide within the U.S. This recall is classified as FDA Class I, indicating a reasonable probability that use of the product may cause serious adverse health consequences or death.
Consumers should stop using the affected trazodone tablets and contact their healthcare provider or pharmacist for guidance. Patients should verify their medication to ensure they are not taking sildenafil instead of trazodone.
The recalled product
- Product
- TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10
- Manufacturer
- AVKARE Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 14,368
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 36783 Exp. 06/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by AVKARE Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · AVKARE Inc.
See all →- ModerateLamotrigine Tablets Recalled for Label Strength Error
FDA (Drugs) · 2022-08-17
- ModeratePhytonadione Tablets 5 mg Recalled Due to Failed Impurities Specification
FDA (Drugs) · 2021-06-23
- ModerateAvKARE Recalls Sildenafil Tablets Due to Packaging Mix-Up with Trazodone
FDA (Drugs) · 2020-12-23
- ModerateAvKARE Recalls Mesalamine Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2020-11-18
- SevereAvKARE Recalls Metformin Hydrochloride Extended-Release Tablets Due to NDMA Impurity
FDA (Drugs) · 2020-06-24
Same hazard · product mix up
See all →- HighAripiprazole 30mg bottle contained voriconazole 50mg tablets instead
FDA (Drugs) · 2026-06-24
- HighLisinopril and hydrochlorothiazide bottle contained a foreign antiretroviral tablet
FDA (Drugs) · 2025-07-23
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- HighKWIK-STICK Quality Control Kit for Culture Media Swab Mix-Up
FDA (Devices) · 2025-06-18
- HighStryker 3.0MM Neuro Precision Head Recalled for Package Labeling Mismatch
FDA (Devices) · 2025-01-29